30 Recruiting Studies Using Upadacitinib
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Upadacitinib
A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo
📍 Advanced Research Associates - Glendale /ID# 259915 — Glendale, Arizona
Vitiligo
View Study & Checklist ➔A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate
📍 Achieve Clinical Research, LLC /ID# 143136 — Birmingham, Alabama
Rheumatoid Arthritis
View Study & Checklist ➔A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis
📍 Ann & Robert H. Lurie Children's Hospital of Chicago /ID# 211162 — Chicago, Illinois
Juvenile Idiopathic Arthritis (JIA)
View Study & Checklist ➔A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy
📍 Cahaba Dermatology & Skin Health Center /ID# 254876 — Birmingham, Alabama
Hidradenitis Suppurativa
View Study & Checklist ➔Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.
📍 Phoenix Children's Hospital /ID# 250135 — Phoenix, Arizona
Ulcerative Colitis
View Study & Checklist ➔Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus
📍 AZ Arthritis and Rheumatology /ID# 261848 — Chandler, Arizona
Systemic Lupus Erythematosus
View Study & Checklist ➔A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433
📍 East View Medical Research, LLC /ID# 171132 — Mobile, Alabama
Crohn's Disease
View Study & Checklist ➔A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)
📍 East View Medical Research, LLC /ID# 171184 — Mobile, Alabama
Ulcerative Colitis (UC)
View Study & Checklist ➔A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
📍 Total Skin and Beauty Derm Ctr /ID# 200548 — Birmingham, Alabama
Atopic Dermatitis
View Study & Checklist ➔Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis
📍 University of Pennsylvania — Philadelphia, Pennsylvania
Axial Spondylarthritis (axSpA)
View Study & Checklist ➔Upadacitinib in Patients Hospitalized With Acute Severe Ulcerative Colitis
📍 UCSF Medical Center — San Francisco, California
UC - Ulcerative Colitis
View Study & Checklist ➔Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis
📍 Tufts Medical Center — Boston, Massachusetts
Arthritis, Rheumatoid
View Study & Checklist ➔A Trial of Upadacitinib for Non-responsive Eosinophilic Esophagitis
📍 University of North Carolina at Chapel Hill — Chapel Hill, North Carolina
EoE
View Study & Checklist ➔Upadacitinib in Treatment of JAK/STAT Pathway Disorders With Activating Mutations
📍 Washington University in St.Louis — St Louis, Missouri
JAK1 GOF
View Study & Checklist ➔Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica
📍 Caja Costarricense del Seguro Social — San José, Provincia de San José
Atopic Dermatitis
View Study & Checklist ➔Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
📍 University of California, San Francisco — San Francisco, California
Psoriasis
View Study & Checklist ➔A Pragmatic Trial of Interleukin-17 Inhibition Versus Janus Kinase Inhibition After Tumor Necrosis Factor-alpha Inhibitor Failure in Axial Spondyloarthritis
📍 The University of Texas health Science Center at Houston — Houston, Texas
Axial Spondyloarthritis (AxSpA)
View Study & Checklist ➔Upadacitinib as a Novel Treatment for Refractory Eyelid Dermatitis
📍 Northwestern University Department of Dermatology — Chicago, Illinois
Eyelid Dermatitis
View Study & Checklist ➔Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
📍 Phoenix Children's Hospital /ID# 253403 — Phoenix, Arizona
Juvenile Idiopathic Arthritis
View Study & Checklist ➔A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
📍 University Hospitals Cleveland Medical Center — Cleveland, Ohio
Psoriatic Arthritis
View Study & Checklist ➔A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
📍 UCSD Medical Center — La Jolla, California
Crohn's Disease
View Study & Checklist ➔Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
📍 UCSF Benioff Children's Hospital - Oakland /ID# 262217 — Oakland, California
Crohn's Disease
View Study & Checklist ➔Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study
📍 Laura Rodriguez Research Institute — San Diego, California
Long COVID
View Study & Checklist ➔A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
📍 Total Skin and Beauty Dermatology Center /ID# 259539 — Birmingham, Alabama
Alopecia Areata
View Study & Checklist ➔Comparison of Medical RESCUE Strategies for Patients With Steroid-refractory Acute Severe Ulcerative Colitis
📍 Hamilton Health Sciences — Hamilton, Ontario
Colitis, Ulcerative
View Study & Checklist ➔A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
📍 Cahaba Dermatology & Skin Health Center /ID# 263855 — Birmingham, Alabama
Atopic Dermatitis
View Study & Checklist ➔A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
📍 Pediatric Skin Research - Miami /ID# 283281 — Miami, Florida
Severe Alopecia Areata
View Study & Checklist ➔A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
📍 Applied Research Center and Wellness Clinic /ID# 268547 — Little Rock, Arkansas
Atopic Dermatitis
View Study & Checklist ➔Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
📍 NYU Langone Health — New York, New York
Rheumatic Disease
View Study & Checklist ➔Feasibility Pilot Sequential Multiple Assignment Randomized Trial (SMART) for Acute Severe Ulcerative Colitis
📍 University of Michigan — Ann Arbor, Michigan
Ulcerative Colitis Acute
View Study & Checklist ➔